Table: Taiko Pharmaceutical - 9-MTH group results

Taiko Pharmaceutical

09/02/2018 06:00

Feb 9 (Reuters)-  
             Taiko Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               6.71                6.06             8.70      
                   (+10.8 pct)         (-0.7 pct)       (+4.9 pct)   
  Operating           1.88                1.76             1.55      
                   (+7.0 pct)          (+37.1 pct)      (+0.4 pct)   
  Recurring           1.70                1.64             1.30      
                   (+4.1 pct)          (+24.1 pct)      (-7.6 pct)   
  Net                 1.15                1.25            900 mln    
                   (-7.8 pct)          (+61.6 pct)      (-14.2 pct)  
  EPS               81.63 yen           91.94 yen        63.74 yen   
  EPS Diluted       81.28 yen           91.05 yen                    
  Ann Div                               20.00 yen        25.00 yen   
  -Q2 div              NIL                 NIL                       
  -Q4 div                               20.00 yen        25.00 yen   
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T 
  ((Tokyo Headline News Desk +813 6441 1812))